December 31, 2019 by Chain Drug Review
CVS Health, Eva Boratto, J.P. Morgan Healthcare Conference, Karen Lynch, Larry Merlo
Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health announced Tuesday that Larry Merlo, president and chief executive officer, Eva Boratto, executive vice president and chief financial officer, and Karen Lynch, executive vice president and president of Aetna will be speaking to investors at the J.P. Morgan Healthcare Conference on January 14, 2020, at approximately 10:00 a.m. PT.
June 4, 2019 by Chain Drug Review
CVS Health, Eva Boratto, HealthHUBs, Larry Merlo
Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — The executive team of CVS Health on Tuesday outlined a series of transformation initiatives at its 2019 Investor Day event, showing how the company plans to accelerate enterprise growth, simplify a consumer health system that is confusing and inconvenient, and position the company for long-term growth and increased shareholder value. The company also
February 15, 2019 by Chain Drug Review
CVS Health, Eva Boratto, SVB Leerink Global Healthcare Conference
Leading Headlines
WOONSOCKET, R.I. — CVS Health announced that Eva Boratto, executive vice president and chief financial officer, will be speaking to investors at the SVB Leerink Global Healthcare Conference on February 28, 2019, at approximately 9:30 a.m. est. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health
January 24, 2019 by Chain Drug Review
Aetna, Eva Boratto, Vitality Re X Limited
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — CVS Health announced that Aetna, a CVS Health business, has entered into a four-year reinsurance arrangement with Vitality Re X Limited as part of its long-term capital management strategy. The arrangement allows CVS Health to reduce its required capital and provides $200 million of collateralized excess of loss reinsurance coverage on a portion of Aetna’s
October 11, 2018 by Chain Drug Review
CVS Health, Edward Ludwig, Eva Boratto, Fernando Aguirre, Larry Merlo
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. – CVS Health announced that three additional Aetna directors with deep insurance company oversight experience — Edward Ludwig, Fernando Aguirre and Roger Farah — will join the CVS Health Board following the completion of its acquisition of Aetna. The appointment of these three Aetna directors, together with the previously announced addition of Mark Bertolini,
April 10, 2017 by Chain Drug Review
Billion Dollar Roundtable, CVS Health, Eva Boratto, supplier diversity
Business, Retail News
WOONSOCKET, R.I. — CVS Health has been recognized by Billion Dollar Roundtable for reaching its goal of spending more than $1 billion with diverse suppliers. With the honor, CVS Health joins the ranks as one of 26 major U.S.-based corporations that provide thought leadership and solutions-driven exploration of key issues in supplier diversity. “We are